Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 9,507,990 | 0 | $574.38M | $558.02M | 78.09% | -$16.35M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 136,180,481 | 0 | $183.84M | $156.61M | 21.91% | -$27.24M |